Horizon Therapeutics plc (HZNP) Company Report Nov. 02, 2022, 06:29 UTC 38 New Form 10-Q for Horizon Therapeutics plc Comment Full text
ADMA Biologics Inc (ADMA) Company Report Nov. 02, 2022, 06:07 UTC 35 ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022 Comment Full text
Intercept Pharmaceuticals Inc (ICPT) Company Report Nov. 01, 2022, 15:20 UTC 34 New Form 10-Q for Intercept Pharmaceuticals, Inc. Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Company Report Nov. 01, 2022, 15:20 UTC 37 Rigel Announces Top-line Results from FOCUS Phase 3 Clinical Trial of Fostamatinib in High Risk Hospitalized COVID-19 Patients Comment Full text
Cytokinetics Inc (CYTK) Company Report Nov. 01, 2022, 15:20 UTC 36 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Comment Full text
Eli Lilly and Company (LLY) Company Report Nov. 01, 2022, 10:40 UTC 33 New Form 10-Q for Eli Lilly and Company Comment Full text
Esperion Therapeutics Inc (ESPR) Company Report Nov. 01, 2022, 08:19 UTC 38 New Form 10-Q for Esperion Therapeutics, Inc. Comment Full text
Pfizer Inc (PFE) Company Report Nov. 01, 2022, 06:00 UTC 33 Pfizer Inc. - Third Quarter 2022 Comment Full text
GT Biopharma Inc. (GTBP) Company Report Oct. 31, 2022, 16:49 UTC 35 New SEC Form for GT Biopharma, Inc. Comment Full text
OncoSec Medical Incorporated (ONCS) Company Report Oct. 31, 2022, 15:34 UTC 33 New SEC Form for OncoSec Medical Incorporated Comment Full text